How The Cannabis Industry Was The Only Clear Winner In The Recent U.S Elections
How the war on drugs suffered another significant defeat
Every morning I write an email discussing the business and the people behind cannabis. If you would like to receive it directly in your inbox, subscribe now.
Friends,
I woke up this morning with a huge smile across my face.
Yesterday as the eyes of the world focused on the U.S presidential election, unknown to many the cannabis industry once again made monumental progress.
As mentioned in yesterdays publication of 4PM a total of the five US states were headed to the ballot-box to vote on whether or not to legalize cannabis, and in every single one of these five states their motions to legalize cannabis passed.
1) Adult use in New Jersey - Population: 8,882,000
2) Adult use in Arizona - Population: 7,279,000
3) Adult use in Montana - Population: 1,069,000
4) Medical use in Mississippi - Population: 2,976,000
5) BOTH medical & adult use in South Dakota - Population: 884,659
Although South Dakota only has a population of just under 900,000 they became the first U.S State to legalize both medical and adult use cannabis in the same ballot.
The State of new Jersey seems to have drawn the most interest, with cannabis sales projected to surpass over $400,000,000 in their first year alone, and if this State is anything like Canada then this number will only continue to increase year over year.
The War on Drugs Suffers Another Significant Defeat
In addition to the cannabis industry winning an outstanding victory in yesterdays election, voters in the State of Oregon and Washington D.C were intent on dealing the war on drugs an additional defeat.
The people of Oregon was seeking to pass legislation that would legalize psilocybin therapy in addition to the decriminalization of all drugs, while Washington D.C was seeking to pass legislation that would decriminalize all psychedelic plants and fungi.
As was the case with cannabis, voters in each States passed all three motions, and with this Oregon regulators are now required to issue licenses for the manufacturing, testing and administering of the psychedelic by January 2, 2023.
In Washington D.C the measure will go into effect after a 30-day review period during which time federal lawmakers have the opportunity to block this reform, however, with over 76.5% support doing so would be ill-advised.
This was a huge win for the cannabis industry, and yesterdays elections comes with a very clear message attached - the war on drugs can only be considered an outstanding failure, and it’s about time we correct this mistake to build a better future.
👉 If you enjoyed reading this post, feel free to share it with friends!
… For more like this, make sure to sign up here: